Polysomnography Technology

Chapter 28


Polysomnography Technology


Wendi M. Nugent and Susan Townsley







Equipment




image Abrasive Skin Prep


image Airflow Thermistor or Thermocouple, and Nasal Pressure Transducer


image Alcohol wipes


image Cotton tipped applicators


image Digital amplifier


image EEG conductive paste


image EEG gold disk electrodes with long lead wires


image Electrode input (jack) box


image Flexible cloth or paper metric measuring tape (washable or disposable)


image Gauze 2 × 2 cm gauze squares


image Hair clips


image Hypoallergenic medical tape


image Nontoxic China marker


image PAP delivery unit with heated humidifier


image Remote operation and digital readout at PSG acquisition device screen


image PAP interfaces (nasal mask, nasal pillows, full face mask, chin support strap)


image Polysomnographic acquisition device


image Pulse oximeter with probe (typically a module within the acquisition device)


image Respiratory effort sensors, thoracic and abdominal belts


image Snap-on long lead wires


image Snoring microphone


image Stick-on surface electrodes (pregelled ECG electrodes)


image Supplemental oxygen (when indicated)


This chapter provides an overview of polysomnographic technology and the duties of the polysomnographic technologist. It is not intended to be an in-depth and comprehensive tool for learning about the technical responsibilities and sleep disorders that are encountered in a sleep lab.


Polysomnography (poly—many, somno—sleep, graphy—tracing) (PSG) is the acquisition of various physiologic signals transmitted to a recording device for interpretation. To acquire and record the physiologic signals, sleep laboratories use computerized technology to digitalize and amplify the acquired signals. A series of electrodes and transducers are attached to the patient to record brainwaves (electroencephalography [EEG]) (Figure 28-1), cardiac wave forms (electrocardiography [ECG]), respiratory events (effort, air flow, saturation of peripheral oxygen [SpO2]), limb movements, snoring, and other parameters during sleep. The data are then available for detailed review to assist qualified physicians in the diagnosis and treatment of sleep disorders. Respiratory therapists (RTs) who have been trained in polysomnographic testing play an integral role in the diagnosis and treatment of sleep-related breathing disorders. Examples of the most common sleep disorders and some frequently performed sleep studies are listed in Boxes 28-1 and 28-2. Of the over 90 identified sleep disorders, 14 are related to sleep-disordered breathing. The most common sleep disorder diagnosed in the sleep lab is obstructive sleep apnea. The goal of the trained respiratory therapist is to help normalize disordered breathing during the overnight procedure. Normalizing breathing through the elimination of sleep apnea helps to restore neurologic sleep patterns and to provide the patient with restorative sleep, decreasing or eliminating the symptoms of snoring and excessive daytime sleepiness. This chapter will cover the indications, methodology, and interpretation of polysomnographic testing for the respiratory therapist (RT).




Box 28-2   Frequently Performed Sleep Studies




• Nocturnal polysomnogram (NPSG): a standard overnight diagnostic sleep study used to assess sleep disorders, including sleep apnea, narcolepsy, parasomnias, periodic limb movement disorders, 24 hour sleep–wake cycle disruptions, and so on. PSG monitoring includes physiological measurements such as respiratory effort and airflow, EEG (brain waves), EOG (eye movements), ECG (heart rhythms), chin and limb EMG (muscle movement), oxygen saturation (SpO2), and snoring. These parameters are standard on every attended sleep lab–based overnight PSG both diagnostic and therapeutic.


• PAP titration study: In lab PSG for the therapeutic PAP treatment of previously diagnosed sleep apnea


• Split-night polysomnography: In lab sleep study that encompasses both the diagnosis and the therapeutic CPAP treatment of sleep apnea


• Multiple Sleep Latency Testing (MSLT): a series of daytime nap PSG studies that measure how long it takes a patient to fall asleep after a full night’s sleep documented by in lab NPSG and to document the presence of REM sleep during the naps. Used for differential diagnosis for excessive daytime sleepiness and narcolepsy. Only EEG, EOG, ECG, and chin EMG are monitored.


• Maintenance of wakefulness testing (MWT): a series of daytime PSG studies developed to provide an objective measure of a patient’s ability to remain awake under standardized conditions for a defined period of time after a full night’s sleep documented by NPSG. Only EEG, EOG, ECG, and chin EMG are monitored. This procedure is often used post PAP or narcolepsy treatment in an attempt to determine treatment efficacy.


ECG, Electrocardiography; EEG, electroencephalography; EMG, electromyography; EOG, electrooculography; REM, rapid eye movement; SPO2, saturation of peripheral oxygen.






» Skill Check Lists


28-1 Assessing the Polysomnography Patient


Patient safety is the primary concern for the RT during diagnostic and positive airway pressure (PAP) titration sleep study procedures. Medical history taking and physical assessment of the patient are the first steps in preparing a patient for polysomnography. It is preferable to obtain a baseline set of vital signs, including blood pressure, prior to testing for all patients. Additionally, any special needs should be addressed prior to initiating patient preparation procedures. Patient-specific accommodations may include a bedside commode or easy access to handicapped bathroom facilities. Padded bedrails may be needed if seizures are suspected. Other assessments include factors complicating communication between the technologist and the patient, for example, the inability to follow simple verbal instructions because of language barriers, neurologic status, anxiety, or hearing loss. The sleep lab should also be prepared to provide supplemental oxygen when it is prescribed. The patient should be queried about medication or tape allergies. Use of medical tapes and adhesive surface electrodes during patient preparation may cause some patients to experience skin irritation. The technologist should also determine if the patient has issues with claustrophobia, before presenting the patient with options for PAP interfaces (masks).




Upon checking into the sleep lab, the patient is asked to complete a presleep questionnaire, which includes information about their activities the night before and the day of testing (Figure 28-2). This questionnaire will provide an indication of the quality of sleep the night prior to testing, napping on the testing day, medications taken prior to arriving at the lab, current state of wakefulness or sleepiness, and consumption of caffeine, alcohol, or other substances that may impact sleep. Comorbidities such as cardiac disease, hypertension, diabetes, seizures, neuromuscular abnormalities, and pulmonary disease should be identified and documented. Disorders such as seizures may alter the process for data acquisition, and interpretation of the sleep study; cardiac abnormalities may present increased risks to the apnea patient during the night; and some medications may alter the appearance of the EEG data or lead to other changes in the recording. The technologist must be cognizant of potential health risks to the patient during the night and any possible recording difficulties (i.e., cardiac abnormalities, excessive movements, required nocturnal medications, etc.) that may impact patient safety.



Permission must be obtained from the patient to monitor, record, and treat sleep-related breathing disorders diagnosed during the sleep study. Standard medical procedure consent forms are signed and dated by the patient as well as the technologist prior to beginning polysomnography. Patients must be made aware that they will be video recorded during the hours of the sleep study. Video recording is essential to polysomnography to document technologist–patient interactions, sleeping position, parasomnias, seizures, or other behavioral events that may occur during the night. The following is the step-by-step process for assessing the polysomnography patient.






Implementation




1. Obtain the patient’s history for medication and substance allergies.


2. Ask the patient to verbally describe the reason he or she has come to the sleep lab, and his or her expectations of the testing procedure and potential treatments to be accomplished during the study.


3. Determine if the patient has had issues with claustrophobia.


4. Determine if the patient has special physical needs to be addressed prior to the start of the procedure (i.e., bedside commode, supplemental oxygen, padded bedrails, etc.).


5. Instruct the patient to complete a presleep questionnaire (see Figure 28-2), which includes information about the patient’s activity the day of testing, prescribed medications already taken and medications to be taken while in the sleep lab, quality of sleep the night prior to testing, time the patient awoke, and any nap(s) taken on the day of testing.


6. Review the completed presleep questionnaire with the patient to ensure accuracy.


7. Determine any comorbidities that may be of concern during the procedure (i.e., cardiovascular abnormalities, diabetes, seizures, neuromuscular disorders, pulmonary disease, etc.).


8. Obtain written permission from the patient to monitor, record, and acquire video during the procedure and to treat breathing-related sleep disorders diagnosed in the sleep lab.





28-2 Educating the Polysomnography Patient


The technologist must be able to clearly communicate the reason for polysomnographic testing and to explain the process of ancillary monitoring device application to the patient. Discuss with the patient sleep-disordered breathing, the negative health effects sleep disorders can have, and the benefits of PAP therapy, should it be indicated. Answer all patient questions and concerns before proceeding with the test to ease patient anxieties and help him or her become more comfortable and compliant with the testing procedures. The following is the step-by-step process for educating the polysomnography patient.









28-3 Introducing and Fitting the Positive Airway Pressure Interface


The process of fitting the PAP interface (mask) may cause anxiety in some patients (Figure 28-3). A detailed explanation of the equipment used for PAP therapy helps alleviate stress for the patient. Several interface options should be presented to the patient with an explanation of pros and cons for each device. Patient comfort is the most important factor for compliance, and sufficient time should be exercised when assisting a patient with choosing the appropriate interface. A proper fit of the interface provides an adequate seal with minimal tension of the headgear. Interface manufacturers provide a wide variety of interface sizes and styles intended to accommodate differences in facial morphology, facial hair, and style preferences. Ask the patient to choose the style of interface that appears most appropriate for him or her, keeping in mind this is a new experience for most patients and that they may have no idea about what is suitable. For example, does the patient like to read or watch TV in bed while falling asleep? Does the patient need glasses? If so, the patient may prefer a nasal pillow type interface that allows the use of glasses while the patient is wearing the interface. Is the patient a mouth breather? If so, try a full-face interface that covers the mouth.





Next, the concept of how PAP works by keeping the airway open should be explained to the patient. Understanding how the PAP device will improve breathing and subsequently sleep and daytime alertness may aid in patient adoption of the PAP devices. (See Box 28-3—PAP Devices.) In the case of patients who experience claustrophobia, ask them to hold the interface in place without the headgear or PAP pressure to acclimate to the feel of the interface, as this allows for the interface to be pulled away at will. Once the patient develops some confidence and comfort with the interface, add 4 cmH20 PAP pressure, and allow the patient to experience breathing with the interface held against the face. Once the patient is able to hold the interface in place without pulling it away, assist with placing the headgear and adjusting the strap tension to keep the interface in proper position. With the interface in place and the PAP unit turned on to the lowest pressure (4 cmH2O), coach the patient to do easy, relaxed breathing through the nose. Often the patient will open the mouth to exhale when first trialing PAP, so encouragement to keep his or her mouth closed may be necessary. Extreme caution should be taken to avoid overtightening the headgear. Overtightening the straps will reduce the cushioning properties of the interface seal and create more leaks. Each interface manufacturer has a predetermined intentional leak for their interface products, and a proper fit will reflect a leak value within the manufacturers’ guidelines.



Box 28-3   PAP Devices


PAP devices have evolved over the years from strictly continuous positive airway pressure (CPAP) to bi-Level positive airway pressure and automated devices. The following is a brief description of each of the device types and how they are used:



• CPAP—positive pressure is set at one pressure level to keep the airway open, acting as a pneumatic splint. Some systems offer a “ramp or flex” pressure setting to allow the patient to get used to gradually increasing levels of positive pressure as they fall asleep.


• Bi-level—inspiratory and expiratory pressures are set, typically 3–4 cm/H20 apart to allow the patient to inhale with a higher level of pressure to open the airway and exhale against a lower level of pressure. Bi-level is especially useful for patients who are placed on higher PAP levels, which are difficult for some patients to exhale against. Bi-level devices also offer ventilator assist with timed and spontaneous options.


• Autotitration, non-invasive ventilation bi-level devices—PAP systems that utilize back-up rates, alarms and servo ventilatory support through sophisticated algorithms to determine the amount of positive pressure required to keep the patient’s airway open on a breath-by-breath basis. These devices are used for treating patients with complex sleep apnea; sleep stage dependent apnea; and patients who may be going through significant physical changes such as weight loss, respiratory diseases such as COPD, restrictive thoracic diseases, complex sleep apnea, Cheyne-Stokes respiration, and neuromuscular diseases.



PAP acclimation in the sleep lab is very time consuming but should not be skipped or shortened to save time. A patient who fully understands PAP therapy and has experienced the device and developed confidence in the therapy will experience a more successful titration process during the night. Provide encouragement to the patient by stating that sleeping with the device will quickly become natural. Experienced PAP users, using a variety of interfaces, find sleeping in any desired position comfortable, with only minor adjustments required, when moving to a new sleeping position (see Figure 28-3).


The following is the step-by-step process for introducing and fitting for a positive airway pressure interface.




Implementation




1. Provide a detailed explanation of the devices used for PAP therapy.


2. Present multiple options of interfaces (masks) to the patient.


3. Provide explanations of the pros and cons for each interface device.


4. Ask the patient to choose the most comfortable interface, and ensure that the appropriate size and fit has been selected for the patient.


5. Demonstrate your understanding of PAP interfaces and appropriate application for each device to the patient.


6. Instruct the patient to sit comfortably on the side of the bed.


7. Explain the concept of PAP and how the device will assist with breathing during the night.


8. Instruct the patient to breathe normally in and out through the nose.


9. Assist the patient with applying the interface and headgear.


10. Introduce PAP at 4 cmH2O pressure.


11. Reassure and support the patient, and ask him or her to relax and breathe easily through the nose throughout the process.


12. Assess for any leak(s) around the edges of the interface, and make adjustments, as needed.


13. Use the minimal amount of headgear tension to maintain an adequate interface seal.


14. Adjust the interface if measured leak is unacceptable, or change the interface if adequate seal cannot be maintained.


15. Instruct the patient to lie down in the supine position:



16. Assure the patient that PAP will be initiated only if indicated by findings on the polysomnogram.


17. Determine patient tolerance of interface and PAP pressure by allowing time to acclimate to any changes with interface or position (allow the patient to move to the preferred sleeping position) and to ensure the patient is comfortable with the process:



18. Remove the supplies from patient’s room, and clean the area, as needed.


19. Remove your gloves, and perform proper hand hygiene prior to leaving the patient’s room.





28-4 Applying Monitoring Devices for Polysomnography


The International 10-20 System of electrode placement was developed by neuroscientists to provide a standard format and common terminology to describe the location of EEG scalp electrodes. By systematically naming and placing the electrodes (Figure 28-4), the EEG data can be compared serially, even when recorded at multiple locations around the world. The 10-20 System of labeling electrode locations is identical in all languages. The naming of the electrode sites correlates with the cortical structures under the electrodes, for example:




The 10-20 System is so termed “10-20” because electrodes are spaced either 10% or 20% of the total distance between a given pair of predetermined landmarks such as the area at the bridge of the nose, or “nasion,” or the protrusion on the back of the head called the “inion,” and so on. The 10-20 System also provides uniform spacing of electrodes for accurate and symmetrical comparison of EEG data.


Nomenclature for the International 10-20 System was developed to give each electrode site a logical alphabetical abbreviation that immediately identifies it with the lobe or area of the brain to which it refers. All of the alphabetical characters refer to the area of brain over which they are located with the exception of “z” which is used for the numerical subscript zero or the midline zero reference (Fpz, Fz, Cz, Pz). Refer to Figure 28-4A for descriptions of the regions covered in electrode placement. Table 28-1 lists the alphabetical abbreviations used.


Stay updated, free articles. Join our Telegram channel

Jun 12, 2016 | Posted by in RESPIRATORY | Comments Off on Polysomnography Technology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access